Anticancer activity of nanoparticles based on PLGA and its Co-polymer: In-vitro evaluation

Iranian Journal of Pharmaceutical Research

Volumn 12, Issue 4, 2013, Pages 623-634

  Amjadi, Issa ^a   Rabiee, Mohammad ^a   Hosseini, Motahare Sadat ^a  

^a AMIRKABIR UNIVERSITY OF TECHNOLOGY   (Iran)

Author keywords

Antitumor activity; Doxorubicin; Nanoparticle; Poly(lactic co glycolic acid); Sustained release

Indexed keywords

DOXORUBICIN; NANOPARTICLE; NANOSPHERE; POLYGLACTIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG POTENCY; DRUG RELEASE; HYDROPHILICITY; INFRARED SPECTROSCOPY; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 84888080724     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Yadav A, Mishra P, Mishra A, Mishra P, Jain S and Agrawal G. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Nanomedicine Nanotech. Biol. Med. (2007) 3: 246-257.
2. American Cancer Society. Cancer Facts & Figures 2009. Atlanta: American Cancer Society; (2009). Available from: URL: oralcancerfoundation. org/facts/pdf/Us_Cancer_Facts. pdf Accessed on 19 January 2012.
3. Chouhan R and Bajpai A. Real time in-vitro studies of doxorubicin release from PHEMA nanoparticles. J. Nanobiotech. (2009) 7: 5-16.
4. Husseini G, Rapoport N, Christensen D, Pruitt J and Pitt W. Kinetics of ultrasonic release of doxorubicin from pluronic P105 micelles. Colloids Surf. B Biointer. (2002) 24: 253-264.
5. Bromberg L and Alakhov V. Effects of polyether-modified poly(acrylic acid) microgels on doxorubicin transport in human intestinal epithelial Caco-2 cell layers. J. Control. Rel. (2003) 88: 11-22.
6. Lebold T, Jung C, Michaelis J and Brauchle C. Nanostructured silica materials as drug-delivery systems for doxorubicin: single molecule and cellular studies. Nano Lett. (2009) 9: 2877-2883.
7. Chavanpatil M, Khdair A and Panyam J. Surfactant-polymer nanoparticles: A novel platform for sustained and enhanced cellular delivery of water-soluble molecules. Pharm. Res. (2007) 24: 803-810.
8. Nidhin M, Indumathy R, Sreeram K and Nair B. Synthesis of iron oxide nanoparticles of narrow size distribution on polysaccharide templates. Bull. Mat Sci. (2008) 31: 93-96.
9. Nobuto H, Sugita T, Kubo T, Shimode S, Yasunaga Y, Murakami T and Ochi M. Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnetic. Int. J. Cancer (2004) 109: 627-635.
10. Cho K, Wang X, Nie SM, Chen Z and Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res. (2008) 14: 1310-1316.
11. Sinha R, Kim GJ, Nie S and Shin DM. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol. Cancer Ther. (2006) 5: 1909-1917.
12. Italia J, Datta P, Ankola D, and Ravi Kumar M. Nanoparticles enhance per oral bioavailability of poorly available molecules: Epigallocatechin Gallate nanoparticles ameliorates cyclosporine induced nephrotoxicity in rats at three times lower dose than oral solution. J. Biomed. Nanotech. (2008) 4: 304-312.
13. Gagliardi M, Silvestri D, Cristallini C, Guadagni M, Crifaci G and Giusti P. Combined drug release from biodegradable bilayer coating for endovascular stents. J. Biomed. Mat. Res. B (2010) 93: 375-385.
14. Janes K, Fresneau M, Marazuela A, Fabra A and Jose Alonso M. Chitosan nanoparticles as delivery systems for Doxorubicin. J. Control. Rel. (2001) 73: 255-267.
15. Gomez-Gaete C, Tsapis N, Besnard M, Bochot A and Fattal E. Encapsulation of dexamethasone into biodegradable polymeric nanoparticles. Int. J. Pharm. (2007) 331: 153-159.
16. Kim E, Durairaj C, Kadam R, Lee S, Mo Y, Geroski D, Kompella U and Edelhauser H. Human scleral diffusion of anticancer drugs from solution and nanoparticle formulation. Pharm. Res. (2009) 26: 1155-1161.
17. Jong W and Borm P. Drug delivery and nanoparticles: Applications and hazards. Int. J. Nanomedicine (2008) 3: 133-149.
18. Arias J. Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery systems. Molecules (2008) 13: 2340-2369.
19. Shukla J, Bandopadhyaya GP, Varma IK, Kumar R and Maulik SK. Morphology and release kinetics of technetium-99m(V) dimercaptosuccinic acid loaded, poly(lactic-co-glycolic) acid microspheric delivery system. An experimental approach that may be used for targeted radiation treatment. Hell. J. Nucl. Med. (2007) 10: 9-13.
20. Park J, Fong PM, Lu J, Russell KS, Booth CJ, Saltzman WM and Fahmy TM. PEGylated PLGA nanoparticles for the improved delivery of doxorubicin. Nanomed. Nanotech. Biol. Med. (2009) 5: 410-418.
21. Albanese A, Tang PS and Chan WC. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu. Rev. Biomed. Eng. (2012) 14:1-16.
22. Muthu MS. Nanoparticles based on PLGA and its copolymer: An overview. Asian J. Pharm. (2009) 3: 266-273.
23. Budhian A, Siegel SJ and Winey KI. Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug content. Int. J. Pharm. (2007) 336: 367-375.
24. Wu Y, Yang W, Wang C, Ju J and Fu S. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int. J. Pharm. (2005) 295: 235-245.
25. Frank A, Rath SK and Venkatraman SS. Controlled release from bioerodible polymers: Effect of drug type and polymer composition. J. Control. Rel. (2005) 102: 333-344.